Medtronic plc (LON:0Y6X)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 87.43B |
| Revenue (ttm) | 25.20B |
| Net Income (ttm) | 3.50B |
| Shares Out | n/a |
| EPS (ttm) | 2.71 |
| PE Ratio | 24.96 |
| Forward PE | 16.24 |
| Dividend | 2.14 (2.32%) |
| Ex-Dividend Date | Jun 27, 2025 |
| Volume | 1,984 |
| Average Volume | 2,600 |
| Open | 90.00 |
| Previous Close | 91.38 |
| Day's Range | 88.76 - 90.00 |
| 52-Week Range | 79.31 - 96.25 |
| Beta | 0.82 |
| RSI | 46.28 |
| Earnings Date | Aug 19, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Medtronic shares snapped six-session winning streak
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
Edwards Lifesciences’ (NYSE: EW) stock surged Friday following a strong second-quarter 2025 earnings report that saw the medical device innovator surpass revenue and earnings expectations, driven by ...
Court Nixes Jury Award Over Medtronic's Heart Valve Infringement Claim
A federal appeals court has sided with Medtronic Plc (NYSE: MDT) in a long-running patent dispute, reversing a jury's finding that the company induced infringement of a Colibri Heart Valve LLC patent...
Medtronic gets EU nod for MiniMed 780G System
Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
GALWAY, Ireland , July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the...
Medtronic wins appeals to avoid $106.5M patent verdict
Medtronic Stock Is Climbing Friday: What's Going On?
On Wednesday, the Centers for Medicare & Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and...
Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist'
When it comes to artificial intelligence stocks , there are multiple that are found in the various portfolios of Ark Funds, led by Cathie Wood. One of Wood's favorite AI stocks has been criticized by ...
Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company
GALWAY, Ireland , July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of ...
Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlook
Merit Medical Systems Inc. (NASDAQ: MMSI) announced a leadership transition on Monday, naming Martha Aronson as its next President and CEO, effective October 3, 2025 . Current CEO Fred Lampropoulos ,...
This $125M Israeli Startup Is Building The World's First Cataract Robot To Solve A Global Crisis: 'There Is No Human Way To Close The Gap'
ForSight Robotics , an Israeli startup aiming to automate cataract and eye surgery, announced Tuesday that it raised $125 million to expand its precision robotics platform, Oryom. The round was led by...
Medtronic: Cash Flow Strength Balanced By Execution Risks
Medtronic: Margin Inflection With Diabetes Spin - Key Drivers
Medtronic: Eyes On The Pipeline And Spin, Shares Still Cheap
Medtronic shows solid fundamentals, steady growth, and dividend strength despite sector risks and rangebound trading. Read why MDT stock is a buy.
Medtronic Board appoints Dr. Joon Lee as a new director
GALWAY, Ireland , June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory He...
Looking Into Medtronic's Recent Short Interest
Medtronic's (NYSE: MDT) short percent of float has fallen 42.06% since its last report. The company recently reported that it has 7.88 million shares sold short , which is 0.62% of all regular shares...
6 Upcoming Dividend Increases
I focus on companies with consistent dividend growth, using a blend of the U.S. Dividend Champions list and NASDAQ data for my selections. This week's highlighted group averages a 5.9% dividend increa...
I'm Buying Dividend Aristocrats At Bargain Basement Prices
Now is an opportune time to focus on income stocks like that offer value and stability amid market volatility. I focus on 2 Dividend Aristocrats that are attractively valued while supporting well-cove...
Medtronic: Solid Recent Performance But Better Options Available
Medtronic Is Separating Its Diabetes Business - Good News For Investors
Medtronic plc (NYSE: MDT) announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction – an initial m...
Medtronic Is Separating Its Diabetes Business - Good News For Investors
Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction – an initial minority I...
Medtronic separate diabetes business to be called MiniMed
Medtronic announces MiniMed as name for planned New Diabetes Company
GALWAY, Ireland , June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following ...
5 Things You Need to Know If You Buy Medtronic Today
Medtronic Announces Intent To Spin Diabetes Business
Deal OverviewOn May 21, 2025, Medtronic plc (NYSE: MDT; $87.44, Market Capitalization: $112.1 billion), a global leader in medical technology, announced its intent to spin off its Diabetes business in...